Literature DB >> 8844477

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis.

T Chiba1, Y Matsuzaki, M Abei, J Shoda, T Aikawa, N Tanaka, T Osuga.   

Abstract

To elucidate the risk factors for hepatocellular carcinoma (HCC) in hepatitis C virus (HCV)-related liver cirrhosis (LC), we examined 204 cirrhotic patients negative for hepatitis B surface antigen and positive for HCV antibodies. The independent influence of various clinical characteristics in these patients was analyzed by multiple logistic regression, and the risk factors for HCC were identified. Multiple logistic regression analysis identified and ranked the following four risk factors: male sex (P < 0.001), habitual heavy drinking (P < 0.005), hepatitis B virus antibody positivity (anti-HBs and/or anti-HBc, P < 0.05), and age greater than 60 years (P < 0.05). The odds ratio of HCC was 4.20 (95% confidence interval; CI, 1.80-9.78) in male patients, 3.27 (95% CI, 1.46-7.30) in habitual heavy drinkers, 2.01 (95% CI, 1.01-3.99) in patients positive for hepatitis B virus antibodies, and 2.06 (95% CI, 1.00-4.23) in patients older than 60 years. The cumulative occurrence rates of HCC after blood transfusion were significantly higher in habitual heavy drinkers (4.8%, 49.4%, and 74.7% at 10, 20, and 30 years, respectively) than in non-drinkers (0%, 21.0%, and 23.3% at 10, 20, and 30 years, respectively, P < 0.0003). The mean interval for progression to LC after blood transfusion was significantly shorter in the habitual heavy drinkers than in the non-drinkers (22.4 +/- 4.4 years vs 28.4 +/- 3.9 years; P < 0.0003). This multivariate analysis revealed that habitual heavy drinking and hepatitis B virus antibody positivity are significant risk factors for HCC in HCV-related liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844477     DOI: 10.1007/bf02355056

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

1.  Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan.

Authors:  K Nishioka; J Watanabe; S Furuta; E Tanaka; H Suzuki; S Iino; T Tsuji; M Yano; G Kuo; Q L Choo
Journal:  Liver       Date:  1991-04

2.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

Review 3.  Hepatocellular carcinoma and hepatitis B virus.

Authors:  R P Beasley; L Y Hwang
Journal:  Semin Liver Dis       Date:  1984-05       Impact factor: 6.115

4.  Effects of ethanol on experimental hepatocarcinogenesis.

Authors:  A Takada; J Nei; S Takase; Y Matsuda
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

5.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.

Authors:  K Ikeda; S Saitoh; I Koida; Y Arase; A Tsubota; K Chayama; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

6.  Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood.

Authors:  M H Chang; P J Chen; J Y Chen; M Y Lai; H C Hsu; D C Lian; Y G Liu; D S Chen
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

7.  High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.

Authors:  N Tanaka; T Chiba; Y Matsuzaki; T Osuga; T Aikawa; K Mitamura
Journal:  Gastroenterol Jpn       Date:  1993-08

8.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.

Authors:  K Tanaka; T Hirohata; S Koga; K Sugimachi; T Kanematsu; F Ohryohji; H Nawata; H Ishibashi; Y Maeda; H Kiyokawa
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

9.  Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol.

Authors:  E Villa; G M Baldini; C Pasquinelli; M Melegari; E Cariani; G Di Chirico; F Manenti
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

10.  The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease.

Authors:  S Takase; M Tsutsumi; H Kawahara; N Takada; A Takada
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

View more
  14 in total

1.  Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma.

Authors:  Philippe Couvert; Alain Carrié; Jacques Pariès; Jenny Vaysse; Audrey Miroglio; Antoine Kerjean; Pierre Nahon; Jamel Chelly; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Ganne-Carrié
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.

Authors:  Yuko Nagaoki; Hiroshi Aikata; Daisuke Miyaki; Eisuke Murakami; Yoshimasa Hashimoto; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Shintaro Takaki; Akira Hiramatsu; Koji Waki; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2011-03-04       Impact factor: 7.527

3.  SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV.

Authors:  Kazuhiro Hamaoka; Sumiko Nagoshi; Kayoko Sugawara; Kayoko Naiki; Yoshihito Uchida; Mie Inao; Nobuaki Nakayama; Kenji Fujiwara; Satoshi Mochida
Journal:  Hepatol Int       Date:  2012-10-06       Impact factor: 6.047

Review 4.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Akira Hiraide; Hiromitsu Saisho
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.

Authors:  Daiki Miki; Hiroshi Aikata; Kiminori Uka; Hiromi Saneto; Tomokazu Kawaoka; Takahiro Azakami; Shintaro Takaki; Soo Cheol Jeong; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Toshiyuki Itamoto; Toshimasa Asahara; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 7.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

8.  Oncogenic potential of hepatitis C virus proteins.

Authors:  Arup Banerjee; Ratna B Ray; Ranjit Ray
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

9.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

10.  Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease.

Authors:  S Okada; T Sato; T Okusaka; H Ishii; M Ikeda; H Nakasuka; H Kosakamoto; M Yoshimori; K Wakabayashi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.